Morbidity-mortality evaluation of the If inhibitor ivabradine in patients with coronary disease and left ventricular dysfunction
Forgotten password ?
  • general information
  • healthcare professionals
  • press office
  • BEAUTIFUL Study
  • Press Conferences
  • Press Kit
  • Press Releases
  • Media Contacts
  • FAQ

BEAUTIFUL Trial
micro
  • New Results
  • Principal Results
  • Fast Facts
  • Rationale
  • Objectives and Design
  • Baseline characteristics
  • Substudies
  • Investigators
  • Slide set
PRESS CONFERENCES
micro
  • ESC Congress 2008
PRESS KIT
micro
PRESS RELEASES
micro
  • 31 August 2009
  • 31 August 2008
  • 4 June 2008
MEDIA CONTACTS
micro
QUESTIONS AND ANSWERS
micro
Home Press Office BEAUTIFUL Study

Substudies of the BEAUTIFUL Study


Two substudies have been scheduled:


top

Contact Site map Search engine
This site is published and updated by the BEAUTIFUL study investigators
Scientific advisor: Prof M. Bertrand